Boston Scientific recalls catheters

FDA classifies recall of Boston Scientific catheters as 'most serious'
The U.S. Food and Drug Administration on Wednesday classified a recall of Boston Scientific's catheters used in a type of minimally invasive surgery as "most serious". The recall involves updating instructions for use rather than removing the device,
Boston Scientific updates cryoablation catheter instructions after 4 death reports
The update followed a higher than expected number of reports of esophageal injury after catheter ablation procedures for atrial fibrillation.
Boston Scientific catheters treating AFib with extreme cooling linked to 4 deaths: FDA alert
Devices already in inventory can be used with the updated instructions by doctors. Patients already treated don’t need to do anything.
Boston Sci issues safety recall for POLARx cryoablation catheters
Boston Scientific (NYSE:BSX) has issued a correction recall for its POLARx and POLARx FIT cryoablation balloon catheters over concerns that they may cause serious esophageal injuries or even death. The company has issued updated instructions for the devices due to a higher-than-expected number of reports of esophageal injury,
Boston Scientific recalls catheters following 4 reported deaths
Boston Scientific has issued a recall for its POLARx Cryoablation Balloon Catheters after four deaths and seven reported injuries linked to astrio-esophageal fistulas, a severe complication during atrial fibrillation ablation procedures.
Boston Scientific recalls pacemakers at risk of triggering permanent safety mode
The FDA is boosting a recall effort from Boston Scientific regarding batteries potentially underpowering a number of the company’s implanted Accolade pacemakers, which may need to be repl | Boston Scientific said it has seen two reported patient deaths linked to the issue.
Boston Scientific price target raised to $110 from $100 at Truist
Truist raised the firm’s price target on Boston Scientific (BSX) to $110 from $100 and keeps a Buy rating on the shares as ...
Boston Scientific Corp. stock rises Friday, still underperforms market
Shares of Boston Scientific Corp. BSX inched 0.33% higher to $88.95 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 1.09% to ...
MassDevice4d
Boston Scientific warns on potential need to replace Accolade pacemaker devices early
The FDA today issued an alert after Boston Scientific warned of the potential need for the early replacement of certain ...
Business Insider22h
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Vivani Medical (VANI) and Merit Medical Systems (MMSI)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Boston Scientific (BSX – Research Report), Vivani Medical (VANI – Research Report) and Merit Medical ...
FierceBiotech1d
FDA elevates Boston Scientific cryoablation correction effort following four deaths
The FDA is elevating a recall from Boston Scientific covering its cryoablation balloon catheters for the treatment of atrial ...